AVD & Greenlane enter a new distribution deal to sell new cartridges
Category: #tech  By Mateen Dalal  Date: 2020-01-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

AVD & Greenlane enter a new distribution deal to sell new cartridges

Advanced Vapor Devices, a renowned producer of vaporizer batteries and cartridges, and Greenlane Holdings, a renowned global seller of premium cannabis accessories, liquid nicotine and CBD products announced a strategic distribution contract for AVD products. This agreement also includes AVD’s complete suite of resin and glass cartridges, disposable and rechargeable batteries, and glass disposable cartridges.

According to the terms of this contract, Greenlane would distribute Easy-Press Glass Cartridge of AVD. This new cartridge is the market’s first glass cartridge to feature a tamper-proof, thumb snap-on locking system. It is designed to decrease bottlenecks in quick high-end, high-production capping and filling environments.

Chief Executive Officer and Chairman of Greenlane, Aaron LoCascio stated that the company is thrilled to collaborate with AVD and to bring its creative vaporization technology to the industry. AVD’s product technology offers fulsome flavors without having to compromise on battery and cartridge integrity or reliability. Greenlane would leverage its expansive distribution network to make the full suite of AVD products available to customers via licensed cannabis dispensaries and vape and smoke shops across North America.

Chief Operating Officer of AVD, Michael Brosgart stated that the company is excited to collaborate with Greenlane and its robust distribution network that spans across Europe, North America, and online via its e-commerce portal.

Brosgart further added that as the cannabis industry is rapidly developing, AVD is aimed at enhancing cartridge technology for customers. Through the company’s partnership with Greenlane, AVD would be capable of providing a broader market along with access to a new series of cartridges. These cartridges would provide reliable performance and be free from harmful toxins.

AVD hardware is produced in a U.S. managed and owned factory. It is cGMP compliant and certified as ISO 9001. Each oil touching part is inert and non-toxic, and cartridges meet strict California Cat III heavy-metal rules. Products of AVD are always subjected to stringent safety assurance protocols and quality control. They are also tested at several stages of the production process.

The AVD leadership team includes major industry experts. Former managers and owners of state-approved extraction labs, processing, cultivation, fulfillment, formulation, and distribution facilities.

 

Source credit: https://investor.gnln.com/news-releases/news-release-details/greenlane-and-avd-announce-distribution-agreement

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Microsoft to fix an active security flaw in Internet Explorer
Microsoft to fix an active security flaw in Internet Explorer
By Mateen Dalal

Microsoft, the renowned American tech giant, reportedly verified the presence of a security flaw that is affecting Internet Explorer (IE) and is being used by hackers. The company also said it is working to find a fix for this bug, which would be rel...

Dermtech signs a commercial & medicare advantage coverage agreement
Dermtech signs a commercial & medicare advantage coverage agreement
By Mateen Dalal

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detect...

CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
By Mateen Dalal

The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-001 respectively U.S.-based bioscience firm CoImmune, Inc., announces partnership with Formula Phar...